Highline Wealth Partners’s Dermata Therapeutics DRMA Stock Holding History

Highline Wealth Partners’s Portfolio DRMA Stock Details DRMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34	Buy	+26	New	+$33	﹤0.01%	1403

Highline Wealth Partners's DRMA Position: Q2 2026 in Review

Highline Wealth Partners opened a new position in Dermata Therapeutics (DRMA) in Q2 2026: 26 shares worth $34. The stake represents ﹤0.01% of the portfolio and ranks #1403 among its holdings.

1 fund tracked by Wall St. Rank holds DRMA as of Q2 2026.

Highline Wealth Partners held 26 shares of Dermata Therapeutics worth $34 as of Q2 2026.
Dermata Therapeutics was a new Highline Wealth Partners position in Q2 2026.
Dermata Therapeutics made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #1403 holding.
1 fund tracked by Wall St. Rank held Dermata Therapeutics as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.